104及105年度食品摻加西藥檢驗案件分析   全文下載

Survey on Pharmaceutical Adulterants in Dietary Supplements in the Year 2015/16

食品藥物管理署於104及105年度受理食品摻加西藥檢驗案件共計672件檢體，其中250件檢出西藥或非標示成分，檢出率為37.2%。依受理案件類別統計，屬縣市政府衛生局轉送消費者申請案件及司法檢警調等機關送驗之服務案件有382件，檢出207件（54.2%）；屬衛生行政機關送驗之抽查案件有290件，檢出43件（14.8%）。依檢體標示或送驗單位指定之檢驗類別進行統計，檢出件數最多者為減肥類（147件），其次為補腎滋養類（壯陽類）（63件）。依檢出成分頻率排序，前3名依序為Sibutramine、Sildenafil及Phenolphthalein。檢出成分除了一般西藥成分外，104及105年度亦檢出壯陽西藥成分Sildenafil、Tadalafil、Vardenafil及減肥西藥成分Fenfluramine、Sibutramine之類緣物共13種，相關檢驗結果及趨勢分析將提供行政管理單位制定政策之參考。

In this report, 672 samples of commercial dietary supplements were analyed for the presence of pharmaceutical adulterants from the year 2015 to 2016. The results showed that 37.2% (250/672) of the samples were adulterated. Among them, 382 samples from consumer service centers of the local health authorities and other governmental institutions were found 54.2% (207/382) adulterated. The 290 inspection samples from local health authorities were found 14.8% (43/290) adulterated. In most cases, the pharmaceutical adulterants were used for weight loss (147 samples) and erectile dysfunction treatment (63 samples). The top three were sibutramine, sildenafil and phenolphthalein. In addition to pharmaceutical chemicals, thirteen analogues of fenfluramine, sibutramine, sildenafil, tadalafil and vardenafil were found. This report will be provided to administrative authorities as reference in policy making.